| scholarly article | Q13442814 |
| P2093 | author name string | C Li | |
| B Bapat | |||
| B A Alman | |||
| P2860 | cites work | Binding of GSK3beta to the APC-beta-catenin complex and regulation of complex assembly | Q24312910 |
| Constitutive transcriptional activation by a beta-catenin-Tcf complex in APC-/- colon carcinoma | Q24336272 | ||
| Activation of beta-catenin-Tcf signaling in colon cancer by mutations in beta-catenin or APC | Q24336321 | ||
| Identification and cloning of TCF-1, a T lymphocyte-specific transcription factor containing a sequence-specific HMG box | Q24561560 | ||
| Structural basis for DNA bending by the architectural transcription factor LEF-1 | Q27729834 | ||
| Identification of FAP locus genes from chromosome 5q21 | Q28300247 | ||
| The CD4 and CD8 T cell surface antigens are associated with the internal membrane tyrosine-protein kinase p56lck | Q28506433 | ||
| APC mutation analysis by chemical cleavage of mismatch and a protein truncation assay in familial adenomatous polyposis | Q36080111 | ||
| Deletion of an amino-terminal sequence beta-catenin in vivo and promotes hyperphosporylation of the adenomatous polyposis coli tumor suppressor protein | Q36561208 | ||
| An aberrant lck mRNA in two human T-cell lines | Q36672121 | ||
| Alterations of the lymphocyte-specific protein tyrosine kinase (p56lck) during T-cell activation | Q36847174 | ||
| Expression of alternatively spliced lck transcripts from the proximal promoter in colorectal cancer derived cell lines. | Q41188954 | ||
| Increased beta-catenin protein and somatic APC mutations in sporadic aggressive fibromatoses (desmoid tumors). | Q42082840 | ||
| Loss of beta-catenin regulation by the APC tumor suppressor protein correlates with loss of structure due to common somatic mutations of the gene | Q46906570 | ||
| Expression of the lck tyrosine kinase gene in human colon carcinoma and other non-lymphoid human tumor cell lines | Q48339399 | ||
| Aggressive fibromatosis (desmoid tumor) is a monoclonal disorder. | Q50962782 | ||
| Desmoid tumor is a clonal cellular proliferation: PCR amplification of HUMARA for analysis of patterns of X-chromosome inactivation. | Q50969679 | ||
| Identification and cloning of TCF-1, a T lymphocyte-specific transcription factor containing a sequence-specific HMG box | Q61772815 | ||
| Desmoid fibromatosis is a clonal process | Q71556935 | ||
| Regulation of proliferation and platelet-derived growth factor expression in palmar fibromatosis (Dupuytren contracture) by mechanical strain | Q71730161 | ||
| In situ end-labelling detects DNA strand breaks in apoptosis and other physiological and pathological states | Q72818153 | ||
| An alternative pathway for expression of p56lck from type I promoter transcripts in colon carcinoma | Q73994513 | ||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | aggressive fibromatosis | Q475086 |
| polyposis | Q2103081 | ||
| P304 | page(s) | 709-714 | |
| P577 | publication date | 1998-09-01 | |
| P1433 | published in | The American Journal of Pathology | Q4744259 |
| P1476 | title | Adenomatous polyposis coli gene mutation alters proliferation through its beta-catenin-regulatory function in aggressive fibromatosis (desmoid tumor). | |
| P478 | volume | 153 |
| Q50058176 | A Metabolomics Pilot Study on Desmoid Tumors and Novel Drug Candidates |
| Q34292713 | A high throughput screen identifies Nefopam as targeting cell proliferation in β-catenin driven neoplastic and reactive fibroproliferative disorders |
| Q34521165 | A mutant PTH/PTHrP type I receptor in enchondromatosis |
| Q33894889 | A prognostic nomogram for prediction of recurrence in desmoid fibromatosis |
| Q34298352 | Abdominal pain and colonic obstruction from an intra-abdominal desmoid tumor. |
| Q44071251 | Anticancer-drug-induced apoptotic cell death in leukemia cells is associated with proteolysis of beta-catenin |
| Q33443489 | Beta-catenin and transforming growth factor beta have distinct roles regulating fibroblast cell motility and the induction of collagen lattice contraction |
| Q73009038 | Beta-catenin in soft tissue sarcomas: expression is related to proliferative activity in high-grade sarcomas |
| Q43193598 | Beta-catenin is a mediator of the response of fibroblasts to irradiation |
| Q43151528 | Beta-catenin mediates soft tissue contracture in clubfoot |
| Q51413671 | CTNNB1 genotyping and APC screening in pediatric desmoid tumors: a proposed algorithm. |
| Q34128162 | Cadherin and catenin alterations in human cancer |
| Q34590630 | Current trends in the management of extra-abdominal desmoid tumours |
| Q52136489 | Cyclooxygenase-two (COX-2) modulates proliferation in aggressive fibromatosis (desmoid tumor). |
| Q91030509 | Desmoid Tumor Presenting as a Typical Cervical Dumbbell Tumor:A Case Report and Literature Review |
| Q53667021 | Desmoid tumor with ossification in chest wall: possible involvement of BAMBI promoter hypermethylation in metaplastic bone formation. |
| Q38178206 | Desmoid tumors of the head and neck: a therapeutic challenge |
| Q37449070 | Desmoid tumors: need for an individualized approach |
| Q36641413 | Desmoids in familial adenomatous polyposis are monoclonal proliferations |
| Q33361554 | Differential diagnosis of gastrointestinal stromal tumor and other spindle cell tumors in the gastrointestinal tract based on immunohistochemical analysis |
| Q45353706 | FOSL1 as a candidate target gene for 11q12 rearrangements in desmoplastic fibroblastoma |
| Q38081247 | Fibroblastic tumors of intermediate malignancy in childhood |
| Q34331851 | Fibromatoses in childhood: the desmoid/fibromatosis complex |
| Q92617100 | Gastric aggressive fibromatosis: report of a case and review of the literature |
| Q73592556 | Genotype and phenotype factors as determinants of desmoid tumors in patients with familial adenomatous polyposis |
| Q52094884 | Growth factors regulate beta-catenin-mediated TCF-dependent transcriptional activation in fibroblasts during the proliferative phase of wound healing. |
| Q21263192 | Human sterile alpha motif domain 9, a novel gene identified as down-regulated in aggressive fibromatosis, is absent in the mouse |
| Q38345717 | Identification of IGFBP-6 as a significantly downregulated gene by beta-catenin in desmoid tumors. |
| Q36694843 | Invasion and MMP expression profile in desmoid tumours |
| Q34112664 | Management of recurrent desmoid tumor after surgery and radiation: role of cytotoxic and non-cytotoxic therapies |
| Q33814311 | Mechanism and function of signal transduction by the Wnt/beta-catenin and Wnt/Ca2+ pathways |
| Q37131523 | Mesenchymal Tumors Can Derive from Ng2/Cspg4-Expressing Pericytes with β-Catenin Modulating the Neoplastic Phenotype. |
| Q35994704 | Near universal detection of alterations in CTNNB1 and Wnt pathway regulators in desmoid-type fibromatosis by whole-exome sequencing and genomic analysis |
| Q34674007 | Optimal therapy for desmoid tumors: current options and challenges for the future |
| Q54540196 | Pathogenic mutations and rare variants of the APC gene identified in 75 Belgian patients with familial adenomatous polyposis by fluorescent enzymatic mutation detection (EMD). |
| Q36193701 | Pediatric aggressive fibromatosis: a retrospective analysis of 13 patients and review of literature |
| Q77505452 | Possible association between higher beta-catenin mRNA expression and mutated beta-catenin in sporadic desmoid tumors: real-time semiquantitative assay by TaqMan polymerase chain reaction |
| Q73270781 | Predominance of beta-catenin mutations and beta-catenin dysregulation in sporadic aggressive fibromatosis (desmoid tumor) |
| Q73131539 | Prognostic value of the preserved expression of the E-cadherin and catenin families of adhesion molecules and of beta-catenin mutations in synovial sarcoma |
| Q34554227 | Prolonged beta-catenin stabilization and tcf-dependent transcriptional activation in hyperplastic cutaneous wounds |
| Q36386037 | Role of β-catenin expression in paediatric mesenchymal lesions: a tissue microarray-based immunohistochemical study |
| Q38270716 | Soft tissue tumors of the trunk: management of local disease in the breast and chest and abdominal walls |
| Q39573667 | Superficial fibromatoses are genetically distinct from deep fibromatoses |
| Q37632825 | Targeted therapies: the rare cancer paradigm |
| Q36623084 | Tcf-3 expression and beta-catenin mediated transcriptional activation in aggressive fibromatosis (desmoid tumour). |
| Q35006864 | Testosterone regulates cell proliferation in aggressive fibromatosis (desmoid tumour). |
| Q34192072 | The Wnt signaling pathway and its role in tumor development |
| Q34068062 | beta-Catenin stabilization dysregulates mesenchymal cell proliferation, motility, and invasiveness and causes aggressive fibromatosis and hyperplastic cutaneous wounds |
| Q57741160 | ‘Difficult to diagnose’ desmoid tumours: a potential role forCTNNB1mutational analysis |
Search more.